Safety study of EG-101 in healthy women before pre-eclampsia trial
Part of Women’s health & pregnancy clinical trials.
This study tests a new medicine, EG-101, in healthy women to see if it is safe and to learn how the body processes it. This is a first step before studying it in pregnant women with severe pre-eclampsia, a serious condition of high blood pressure during pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a female aged 18 to 55 years.
- You are in good general health, with a body mass index (BMI) between 18.5 and 32.
- You are not pregnant, not breastfeeding, and not planning to become pregnant during the study. You must use effective birth control or be past menopause or surgically sterile.
- You have no history of drug or alcohol abuse in the past 6 months.
- You are not allergic to the study drug or its ingredients, and you have no history of serious allergies or asthma.
- You do not have a history of fainting or conditions that could cause fainting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies ways to lower the risk of pre-eclampsia (dangerous high blood pressure in pregnancy) in women who are having a first pregnancy through IVF/ICSI or who have PCOS. It’s aimed at people considered higher risk for pre-eclampsia.
This study looks at how the body supports pregnancy in the early weeks and whether problems with that support can lead to complications. By tracking pregnancies from the start, researchers hope to find ways to predict and prevent issues like poor placental function.
This trial follows women who have had preeclampsia to learn more about their health after pregnancy. It collects blood and tissue samples to find markers that could improve future care.
This study tests whether taking a low dose of aspirin early in pregnancy can lower the risk of losing the baby or developing preeclampsia (a serious condition with high blood pressure). It is for women who have risk factors for these problems and are very early in pregnancy (less than 7 weeks).
This pilot study looks at tiny particles in blood (microvesicles) to learn how they differ in women with threatened preterm delivery, with or without pre-eclampsia. Results may help doctors better identify risk and improve care for early delivery.
This study looks at factors related to pre-eclampsia (a pregnancy blood-pressure condition) in people who are more than 10 weeks pregnant. It may help improve early understanding and care for future pregnancies.
Hear when a new Pre-Eclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.